A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes

scientific article published in July 2005

A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JDIACOMP.2005.01.004
P8608Fatcat IDrelease_ujo27qrsefexdaolkeweicwul4
P698PubMed publication ID15993356

P50authorJames M. HempeQ42872304
P2093author name stringRobert J McCarter
Stuart A Chalew
Jessica L Thomson
Jacinta Thomas
P2860cites workBiological variation of glycated hemoglobin. Implications for diabetes screening and monitoring.Q51570814
P433issue4
P921main subjectglycosylationQ898365
P304page(s)218-222
P577publication date2005-07-01
P1433published inJournal of Diabetes and its ComplicationsQ15763696
P1476titleA comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes
P478volume19

Reverse relations

cites work (P2860)
Q35680892Association between Inflammation and Biological Variation in Hemoglobin A1c in U.S. Nondiabetic Adults.
Q37193623Association of glycation gap with mortality and vascular complications in diabetes.
Q38129464Biological variation and hemoglobin A1c: relevance to diabetes management and complications
Q42869454Does A1c consistently reflect mean plasma glucose?
Q37111267Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus
Q35123412Evidence for consistency of the glycation gap in diabetes
Q36842619Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation
Q84942366Glycated hemoglobin A₁c (HbA₁c) and diabetes: a new era?
Q88887505Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes
Q37798056Review of hemoglobin A1c in the management of diabetes
Q35630701The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial
Q43832605Two-dimensional analysis of glycated hemoglobin heterogeneity in pediatric type 1 diabetes patients
Q61448561Update on biomarkers of glycemic control
Q28533840Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited

Search more.